Deutsche Bank’s SBC Medical Group SBC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-7,236
Closed -$33.6K 3763
2025
Q2
$33.6K Buy
+7,236
New +$28.6K ﹤0.01% 3451
2024
Q1
Sell
-13,533
Closed -$144K 3680
2023
Q4
$144K Hold
13,533
﹤0.01% 3041
2023
Q3
$145K Buy
+13,533
New +$143K ﹤0.01% 2982
2023
Q2
Sell
-121,521
Closed -$1.27M 3963
2023
Q1
$1.27M Hold
121,521
﹤0.01% 1951
2022
Q4
$1.24M Buy
+121,521
New +$1.23M ﹤0.01% 1917

Other funds holding SBC

Deutsche Bank's SBC Position: Q3 2025 in Review

Deutsche Bank sold out of SBC Medical Group (SBC) in Q3 2025, closing a stake of 7,236 shares — an estimated $33.6K sold.

Deutsche Bank first reported a position in SBC in Q4 2022 and held it in 5 quarters. The position peaked at $1.27M in Q1 2023. 42 funds tracked by Wall St. Rank hold SBC as of Q3 2025.

  • Deutsche Bank reported no remaining SBC Medical Group position as of Q3 2025 after selling out during the quarter.
  • Deutsche Bank sold 7,236 SBC Medical Group shares in Q3 2025, an estimated $33.6K.
  • Deutsche Bank first reported a position in SBC Medical Group in Q4 2022 and held it in 5 quarters.
  • Deutsche Bank's SBC Medical Group position peaked at $1.27M in Q1 2023.
  • 42 funds tracked by Wall St. Rank held SBC Medical Group as of Q3 2025.

Based on Deutsche Bank's 13F filing for Q3 2025, filed 13 Nov 2025.